Charles River Laboratories International
CRL on XNYS, Charles River Laboratories International, Inc.
Measures activity, not value. Not investment advice.
Latest month (Jul 2026)
$65K
0.0× the 3-year median
Last 12 months
$74.7M
+25% vs the 12 months before
Sharp changes
4
federal obligations jump, first federal award, first award from a new federal agency
What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
USAspending.gov obligations by date. Dashed: 3-year median. Incomplete recent periods left out (91-day reporting lag).
See the numbers
| Month of Jul 2026: $65K |
| Month of Jun 2026: $756K |
| Month of May 2026: $8.1M |
| Month of Apr 2026: $14K |
| Month of Mar 2026: $34.8M |
| Month of Feb 2026: $6.6M |
| Month of Jan 2026: $2.8M |
| Month of Dec 2025: $1.8M |
| Month of Nov 2025: $6K |
| Month of Oct 2025: -$50K |
| Month of Sep 2025: $20.2M |
| Month of Aug 2025: -$307K |
| Month of Jul 2025: $75K |
| Month of Jun 2025: -$350K |
| Month of May 2025: $829K |
| Month of Apr 2025: -$11K |
| Month of Mar 2025: $38.5M |
| Month of Feb 2025: $4.2M |
| Month of Jan 2025: $84K |
| Month of Dec 2024: $7.0M |
| Month of Nov 2024: $9K |
| Month of Oct 2024: $89K |
| Month of Sep 2024: $7.5M |
| Month of Aug 2024: $2.0M |
| Month of Feb 2024: $7.4M |
| Month of Jan 2024: $3.2M |
| Month of Dec 2023: $234K |
| Month of Nov 2023: $3.2M |
| Month of Oct 2023: $986K |
| Month of Sep 2023: $15.8M |
| Month of Aug 2023: $4.5M |
| Month of Jul 2023: $852K |
| Month of Jun 2023: $194K |
| Month of May 2023: $936K |
| Month of Apr 2023: $62K |
| Month of Mar 2023: $6.7M |
| Month of Feb 2023: $4.1M |
| Month of Jan 2023: $4.1M |
| Month of Dec 2022: $417K |
| Month of Nov 2022: $7.0M |
| Month of Oct 2022: $732K |
| Month of Sep 2022: $27.3M |
| Month of Aug 2022: $6.7M |
| Month of Jul 2022: $1.0M |
| Month of Jun 2022: -$777K |
| Month of May 2022: $3.1M |
| Month of Apr 2022: -$909K |
| Month of Mar 2022: $11.4M |
| Month of Feb 2022: $1.4M |
| Month of Jan 2022: $4.4M |
| Month of Dec 2021: $5.6M |
| Month of Nov 2021: $1.3M |
| Month of Oct 2021: $484K |
| Month of Sep 2021: $23.8M |
| Month of Aug 2021: $2.3M |
| Month of Jul 2021: $1.8M |
| Month of Jun 2021: -$555K |
| Month of May 2021: $59K |
| Month of Apr 2021: $918K |
| Month of Mar 2021: $13.2M |
What the numbers say
- Federal obligations: $65K in July 2026, 0.0× the 3-year median.
- Federal obligations over 12 months: $62.3M, number 8 of 120 Health Care companies with data (median $214K).
- 4 sharp changes in all loaded history (federal obligations jump, first federal award, first award from a new federal agency).
- New awards in the last 12 months by awarding agency: the largest is Department of Health and Human Services, 5 (100%).
- Latest record: new Department of Health and Human Services contract 75N98026F00001 ($2.7M), public on 23 Sep 2026.
See the numbers
| Department of Health and Human Services | 5 (100%) |
Every measure from this source
5 years, by the period each figure describes
Sharp changes
4 in all loaded history, strongest first
Charles River Laboratories International booked $7.0M in federal contract and grant obligations in December 2024, 30× the same month last year.
Same month last year: $234K; its normal month is $606K.
See the evidence
- This period
- $7.0M (December 2024)
- Normal month (median of 5 earlier)
- $606K
- Typical spread (median absolute deviation)
- $372K
- How far from its usual level
- +6.4
- Same month last year
- $234K
- History used
- 6,301 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Check it at the source: USAspending.gov award search.
Charles River Laboratories International booked $8.1M in federal contract and grant obligations in May 2026, 9.7× the same month last year.
Same month last year: $829K; its normal month is $829K.
See the evidence
- This period
- $8.1M (May 2026)
- Normal month (median of 5 earlier)
- $829K
- Typical spread (median absolute deviation)
- $770K
- How far from its usual level
- +6.3
- Same month last year
- $829K
- History used
- 6,817 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Check it at the source: USAspending.gov award search.
Charles River Laboratories International booked $7.1M in federal contract and grant obligations in November 2020, 3.8× the same month last year.
Same month last year: $1.9M; its normal month is $975K.
See the evidence
- This period
- $7.1M (November 2020)
- Normal month (median of 5 earlier)
- $975K
- Typical spread (median absolute deviation)
- $364K
- How far from its usual level
- +6.1
- Same month last year
- $1.9M
- History used
- 4,809 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Check it at the source: USAspending.gov award search.
Charles River Laboratories International booked $6.8M in federal contract and grant obligations in November 2022, 5.5× the same month last year.
Same month last year: $1.3M; its normal month is $1.3M.
See the evidence
- This period
- $6.8M (November 2022)
- Normal month (median of 5 earlier)
- $1.3M
- Typical spread (median absolute deviation)
- $611K
- How far from its usual level
- +5.6
- Same month last year
- $1.3M
- History used
- 5,539 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Check it at the source: USAspending.gov award search.
The records
Newest first, by the day each became public